Direct Conversion AB:企業の戦略的SWOT分析

◆英語タイトル:Direct Conversion AB - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1857
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Direct Conversion AB – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Direct Conversion AB (Direct Conversion) a subsidiary of Varex Imaging Corp develops, manufactures and markets high-performance X-ray imaging systems for medical, dental and industrial customers. It develops digital 3D-imaging systems for medical and industrial applications based on its proprietary X-ray technologies. The company harnesses its patented XCT -3T technology to provide detectors incorporated into systems used by dentists, radiographers, surgeons, engineers, food scientists and nuclear technologists. The company also offers services for the designing, development and assembly of customized X-ray detectors. The company’s R&D team works in collaboration with other global research organizations to advance photon counting technology. The company operates in Asia, Europe, North America and South America. Direct Conversion is headquartered in Danderyd, Sweden.

Direct Conversion AB Key Recent Developments

Jul 18,2019: Varex Subsidiary Direct Conversion opens application innovation centre in Munich
Nov 20,2018: CTO Christer Ullberg presents direct conversion’s latest technological advances

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Direct Conversion AB – Key Facts
Direct Conversion AB – Key Employees
Direct Conversion AB – Key Employee Biographies
Direct Conversion AB – Major Products and Services
Direct Conversion AB – History
Direct Conversion AB – Company Statement
Direct Conversion AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Direct Conversion AB – Business Description
Business Segment: Dental Sensors
Performance
Business Segment: Exclusivity
Performance
Business Segment: Industrial Sensors
Performance
Business Segment: Medical Sensors
Performance
Business Segment: Others
Performance
Direct Conversion AB – Corporate Strategy
Direct Conversion AB – SWOT Analysis
SWOT Analysis – Overview
Direct Conversion AB – Strengths
Direct Conversion AB – Weaknesses
Direct Conversion AB – Opportunities
Direct Conversion AB – Threats
Direct Conversion AB – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Direct Conversion AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Direct Conversion AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
Direct Conversion AB, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jul 18, 2019: Varex Subsidiary Direct Conversion opens application innovation centre in Munich
Nov 20, 2018: CTO Christer Ullberg presents direct conversion’s latest technological advances
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Direct Conversion AB, Key Facts
Direct Conversion AB, Key Employees
Direct Conversion AB, Key Employee Biographies
Direct Conversion AB, Major Products and Services
Direct Conversion AB, History
Direct Conversion AB, Subsidiaries
Direct Conversion AB, Key Competitors
Direct Conversion AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Direct Conversion AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
Direct Conversion AB, Recent Deals Summary

List of Figures
Direct Conversion AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Direct Conversion AB, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Direct Conversion AB:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OncoMed Pharmaceuticals Inc (OMED):企業の財務・戦略的SWOT分析
    Summary OncoMed Pharmaceuticals Inc (OncoMed) is a clinical-stage biopharmaceutical company focused on discovery and development of novel immuno-oncology (IO) therapeutics for the treatment of cancers. Its pipeline product candidates include navicixizumab, rosmantuzumab, Gitrl-FC Trimer, and anti-TI …
  • GGP Inc:戦略・SWOT・企業財務分析
    GGP Inc - Strategy, SWOT and Corporate Finance Report Summary GGP Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Dart Container Corporation:企業の戦略・SWOT・財務分析
    Dart Container Corporation - Strategy, SWOT and Corporate Finance Report Summary Dart Container Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Care Hospitals:製薬・医療:M&Aディール及び事業提携情報
    Summary Care Hospitals is a healthcare service provider that offers medical care services. The center operates through its specialty departments such as anesthesiology, clinical psychology, obstetrics and gynecology, dietetics and nutrition, ophthalmology and hematology, emergency and general medici …
  • Mitsubishi Chemical Holdings Corporation:戦略・SWOT・企業財務分析
    Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • ILF Consulting Engineers:企業の戦略・SWOT・財務情報
    ILF Consulting Engineers - Strategy, SWOT and Corporate Finance Report Summary ILF Consulting Engineers - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Mindray Medical International Ltd-医療機器分野:企業M&A・提携分析
    Summary Mindray Medical International Ltd (Mindray) is a medical device company. Its major products include multi-parameter patient monitors, telemetry monitoring system, defibrillator, anesthesia machine, surgical lights, ceiling supply units, veterinary monitoring systems, hematology analyzer and …
  • F. Hoffmann-La Roche Ltd (ROG):企業の財務・戦略的SWOT分析
    F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • United Engineers Limited:企業の戦略・SWOT・財務情報
    United Engineers Limited - Strategy, SWOT and Corporate Finance Report Summary United Engineers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • JSR Corp (4185):製薬・医療:M&Aディール及び事業提携情報
    Summary JSR Corp (JSR), formerly Japan Synthetic Rubber Co Ltd is a chemical manufacturing company. It produces a synthetic rubbers, emulsions and plastics. The company, along with its subsidiaries, provides general-purpose synthetic rubbers, special purpose synthetic rubbers, thermoplastic elastome …
  • Epic Pharma LLC-製薬・医療分野:企業M&A・提携分析
    Summary Epic Pharma LLC (Epic Pharma), a subsidiary of Humanwell Healthcare (Group) Co Ltd is a drug company that develops and manufactures generic prescription drugs. The company’s products include citalopram, betaxolol, amlodipine besylate, meperidine hydrochloride, flacoxate hydrochloride, nicard …
  • Harting AG & Co KG:企業の戦略的SWOT分析
    Harting AG & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Titan Pharmaceuticals Inc (TTNP):企業の財務・戦略的SWOT分析
    Summary Titan Pharmaceuticals Inc (Titan) is a pharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio provides probu …
  • Philips Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Philips Healthcare, formerly Philips Medical Systems, undertakes the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlan …
  • Revolution Medicines Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Revolution Medicines Inc (Revolution Medicines) is a drug development company that discovers and develops new medicines and therapies for cancer patients. The company’s programs include SHP2 Program, 4EBP1 Program and mTORC1 Program. It develops REVBLOCKS platform, an integrated suite of mod …
  • Evraz Plc:企業の戦略・SWOT・財務情報
    Evraz Plc - Strategy, SWOT and Corporate Finance Report Summary Evraz Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • CanBas Co Ltd (4575):製薬・医療:M&Aディール及び事業提携情報
    Summary CanBas Co Ltd (CanBas) is a clinical stage biopharmaceutical company that develops therapeutics for cancer. The company discovers and develops of novel therapeutics in the field of oncology targeting the cell cycle. It provides two clinical oncology programs, CBP501 and CBS9106 with mutually …
  • Fletcher Building Ltd:戦略・SWOT・企業財務分析
    Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report Summary Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pluspetrol SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Pluspetrol SA (Pluspetrol), a subsidiary of Pluspetrol Resources Corporation N.V. is an oil and gas company that produces oil and gas products. The company’s products include LPG, natural gas, crude oil, liquid fuel, liquid gas and others. It explores and develops oil and gas reserves based …
  • GMR Infrastructure Ltd (GMRINFRA):電力:M&Aディール及び事業提携情報
    Summary GMR Infrastructure Limited (GMR), a subsidiary of GMR Group, is a construction company. The company executes various projects across airport, energy, transportation and urban infrastructure sectors. The company owns and operates Delhi's Indira Gandhi International Airport, Rajiv Gandhi Inter …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆